Literature DB >> 30789591

The Impact of HIV Infection on TB Disparities Among US-Born Black and White Tuberculosis Patients in the United States.

Suzanne M Marks1, Dolly J Katz, Amy L Davidow, Melissa A Pagaoa, Larry D Teeter, Edward A Graviss.   

Abstract

BACKGROUND/
OBJECTIVES: US-born non-Hispanic black persons (blacks) (12% of the US population) accounted for 41% of HIV diagnoses during 2008-2014. HIV infection significantly increases TB and TB-related mortality. TB rate ratios were 6 to 7 times as high in blacks versus US-born non-Hispanic whites (whites) during 2013-2016. We analyzed a sample of black and white TB patients to assess the impact of HIV infection on TB racial disparities.
METHODS: In total, 552 black and white TB patients with known HIV/AIDS status were recruited from 10 US sites in 2009-2010. We abstracted data from the National TB Surveillance System, medical records, and death certificates and interviewed 477 patients. We estimated adjusted odds ratios (AORs) with 95% confidence intervals (CIs) for associations of TB with HIV infection, late HIV diagnosis (≤3 months before or any time after TB diagnosis), and mortality during TB treatment.
RESULTS: Twenty-one percent of the sample had HIV/AIDS infection. Blacks (AOR = 3.4; 95% CI, 1.7-6.8) and persons with recent homelessness (AOR = 2.5; 95% CI, 1.5-4.3) had greater odds of HIV infection than others. The majority of HIV-infected/TB patients were diagnosed with HIV infection 3 months or less before (57%) or after (4%) TB diagnosis. Among HIV-infected/TB patients, blacks had similar percentages to whites (61% vs 57%) of late HIV diagnosis. Twenty-five percent of HIV-infected/TB patients died, 38% prior to TB diagnosis and 62% during TB treatment. Blacks did not have significantly greater odds of TB-related mortality than whites (AOR = 1.1; 95% CI, 0.6-2.1).
CONCLUSIONS: Black TB patients had greater HIV prevalence than whites. While mortality was associated with HIV infection, it was not significantly associated with black or white race.

Year:  2019        PMID: 30789591      PMCID: PMC6693994          DOI: 10.1097/PHH.0000000000000949

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  18 in total

1.  HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group.

Authors:  J L Jones; D L Hanson; M S Dworkin; K M DeCock
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

2.  Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.

Authors:  Patrice Severe; Marc Antoine Jean Juste; Alex Ambroise; Ludger Eliacin; Claudel Marchand; Sandra Apollon; Alison Edwards; Heejung Bang; Janet Nicotera; Catherine Godfrey; Roy M Gulick; Warren D Johnson; Jean William Pape; Daniel W Fitzgerald
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  Latent tuberculous infection testing among HIV-infected persons in clinical care, United States, 2010-2012.

Authors:  E J Reaves; N S Shah; A M France; S B Morris; S Kammerer; J Skarbinski; H Bradley
Journal:  Int J Tuberc Lung Dis       Date:  2017-10-01       Impact factor: 2.373

4.  Knowledge and Attitudes About Tuberculosis Among U.S.-Born Blacks and Whites with Tuberculosis.

Authors:  Meredith M Howley; Chaturia D Rouse; Dolores J Katz; Paul W Colson; Yael Hirsch-Moverman; Rachel A Royce
Journal:  J Immigr Minor Health       Date:  2015-10

5.  Timely HIV diagnosis and HIV/TB comanagement among California patients in 2008.

Authors:  Darryl Kong; James P Watt; Suzanne M Marks; Jennifer M Flood
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

6.  Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-01-16       Impact factor: 17.586

7.  Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Authors:  Motasim Badri; Douglas Wilson; Robin Wood
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

8.  Tuberculosis - United States, 2016.

Authors:  Kristine M Schmit; Zimy Wansaula; Robert Pratt; Sandy F Price; Adam J Langer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-03-24       Impact factor: 17.586

9.  HIV Care Outcomes Among Blacks with Diagnosed HIV - United States, 2014.

Authors:  Andre F Dailey; Anna Satcher Johnson; Baohua Wu
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-03       Impact factor: 17.586

10.  Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection.

Authors:  Andrey S Borisov; Sapna Bamrah Morris; Gibril J Njie; Carla A Winston; Deron Burton; Stefan Goldberg; Rachel Yelk Woodruff; Leeanna Allen; Philip LoBue; Andrew Vernon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-06-29       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.